BiotechTube

REOLYSIN + Gemcitabine

Phase 2Completed
0 watching 0 views this week⚡ Active
44
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Metastatic Pancreatic Adenocarcinoma

Conditions

Metastatic Pancreatic Adenocarcinoma

Trial Timeline

Oct 1, 2009 → Feb 1, 2015

NCT ID
NCT00998322

About REOLYSIN + Gemcitabine

REOLYSIN + Gemcitabine is a phase 2 stage product being developed by Oncolytics Biotech for Metastatic Pancreatic Adenocarcinoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00998322. Target conditions include Metastatic Pancreatic Adenocarcinoma.

Hype Score Breakdown

Clinical
17
Activity
12
Company
2
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT00998322Phase 2Completed

Competing Products

20 competing products in Metastatic Pancreatic Adenocarcinoma

See all competitors
ProductCompanyStageHype Score
Autologous Mesothelin-specific TCR-T Cells + Cyclophosphamide + Fludarabine + BendamustineLonzaPhase 1
30
Pemetrexed + Erlotinib + Pemetrexed + ErlotinibEli LillyPhase 2
52
SRF617 + etrumadenant + zimberelimabCoherus BioSciencesPhase 2
44
ZN-c3 + Encorafenib + CetuximabZentalis PharmaceuticalsPhase 1
25
AbemaciclibEli LillyPre-clinical
23
Ramucirumab + Placebo + Erlotinib + Gefitinib + OsimertinibEli LillyPhase 3
77
SYNB1891 + AtezolizumabSynlogicPhase 1
25
CT-P6 + Herceptin + PaclitaxelCelltrionPhase 3
77
CT-P6 + Herceptin + PaclitaxelCelltrionPhase 1/2
41
SPYK04Chugai PharmaceuticalPhase 1
33
LUNA18 + CetuximabChugai PharmaceuticalPhase 1
33
Induction therapyChugai PharmaceuticalPhase 2
52
Trastuzumab + Pertuzumab + Docetaxel + Paclitaxel + Nab-paclitaxel + Vinorelbine + Eribulin + Capecitabine + GemcitabineChugai PharmaceuticalPhase 3
77
Paclitaxel + Bevacizumab + Letrozole + Anastrozole + Exemestane + Fulvestrant + Goserelin + leuprorelinChugai PharmaceuticalPhase 2
52
bevacizumab + PaclitaxelChugai PharmaceuticalPhase 2
52
Bevacizumab + 5-fluorouracil + Leucovorin calcium + Irinotecan hydrochloride + Oxaliplatin + CapecitabineChugai PharmaceuticalPhase 2
52
GC33Chugai PharmaceuticalPhase 1
33
Gemcitabine and UFTE chemotherapyYuhanPhase 2
52
Trastuzumab Deruxtecan + Cisplatin + Carboplatin + Pembrolizumab + PemetrexedDaiichi SankyoPhase 3
77
DS9051bDaiichi SankyoPhase 1
33

Other Products from Oncolytics Biotech

REOLYSIN + Carboplatin + Paclitaxel + PlaceboPhase 3
69
Bevacizumab + FOLFIRI + PelareorepPhase 2
44
Pemetrexed and Reolysin (and safety run-in) + Pemetrexed + Docetaxel and Reolysin + DocetaxelPhase 2
44
REOLYSIN + Carboplatin + PaclitaxelPhase 2
44
REOLYSIN® + Carboplatin + PaclitaxelPhase 2
44